Stocks in Play - 3rd March 2026

Today in Focus: MASS or Sit On Hands

Trading Services I Use in my Trading:

StockAnalysis.com - I’ve been using Stock Analysis as a super cheap but reliable method of looking at New and Upcoming IPOs, Earnings Calendars and most notably KPIs (Key Performance Indicators). Stock Analysis allows you to view the KPIs for many companies with up to date metrics and segments that you can cross reference against Earnings Results. This is incredibly important when understanding what metrics move a stock. At $65 per year it’s a no brainer. They’ve given me a discount code if you use IRISHBORNINVESTOR they will give you another 10% Off.

Situational Awareness

Market Condition: Significant Gap Down, VIX Spike

Commentary: We had a nice recovery yesterday and a strong day in many names. Unfortunate strong gap down again today coupled with VIX Spike. Once again we need the VIX to sell off here at the open. If it accelerates then the indices are likely to see lower. 200MA at $587.

VIX is either taking it’s last gap today or is about to launch higher to $30+. I guess there are perceived market disruptions, oil disruptions etc. Not sure. Regardless today is a day for caution. No need to be a hero. None of my positions are near stop out. Will remain calm and see where the day takes us.

Upcoming Earnings:
After Hours: RIGL, BGS, MEC, RYAM, ACEL, IBRX, NPCE, SWIM
Before Open: ANF, OCGN, EYE, HLLY

Trade Updates:

Current Positions: FSLY, DELL, GLW, INNV, NKTR, PVLA, YOU, ROIV, VG, CRLC, UAMY

In Play

MASS:  Turnaround Story - Return to Profitability

Key Metrics: Industry Group: Medical Devices, Market Cap: 268.56M, Float: 26.73M, Short Interest: 14.32%, Days to Cover: 9.58, Sales Y/Y TTM: 4.49%, EPS Y/Y TTM: 3.61%, Earnings: Mar 03 BMO, Exchange: NASDAQ

Catalyst: Strategic transformation and Turnaround story. Achieved Positive EBITDA. Strong Beat on Revs, EPS Beat. Strong Beat on GMs. Inflection point on Adjusted EBITDA. Organic Revenue drives. Positive Net Income Swing. ARR Growing strongly and accelerating. Strategic Transformation (restructuring) working. Defence and Government TAM Accelerating.

The company make chemicals testing/Hazmat hand held devices with government/defense use cases.

High Short Interest, Low Float. Defence Theme. Good Chart. Needs good RVOL at the open. Spread may be an issue.

Sector-Specific KPIs (Industrials/Defense Tech):Installed base: 3,736 devices (+24% YoY) — book-to-bill proxy; accelerating placements. Recurring revenue mix: 32% of Q4 revenue / 35% FY — improving revenue quality

• "2025 was a defining year for 908 Devices as we strengthened our operating model, expanded margins, and achieved Adjusted EBITDA positivity in the fourth quarter. Our disciplined execution led to strong growth." — CEO Kevin Knopp

• "The structural changes we have implemented combined with a solid balance sheet give us financial flexibility to focus resources on the growing demand across the vital health, safety, and defense-tech markets we serve."

Delayed Reaction/Continuation Watchlist:

Monitoring: None today.

Delayed Reaction Watchlist (TradingView Link)

_{Note: This is my methodology for identifying stocks in play. There are many valid approaches to trading catalysts—find the setups, timeframes, and risk parameters that align with your strategy.}